51162709 Cistinexine

Definition

UNSPSC 51162709

This classification denotes a mucolytic agent and expectorant with the molecular formula C50H60Br4N6O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 62VR67FK8E, chemically known as 2-oxa-7,8-dithia-4,11-diazadodecan-12-oic acid, 5,10-bis(((2,4-dibromo-6-((cyclohexylmethylamino)methyl)phenyl)amino)carbonyl)-3-oxo-1-phenyl-, phenylmethyl ester, (r-(r*,r*))- but more generally known as cistinexine, which bears US NIH Compound Identifier 65644. European Medicines Agency schedules Cistinexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07484MIG. The term CISTINEXINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 40, No. 6, 1986, List 26). CISTINEXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cistinexine under HS 29309016 and SITC 51549. As of Q4 2014, CISTINEXINE remains US FDA's Preferred Term for this commodity. Cistinexine bears US NLM identifiers UMLS ID C0627299 and NCI Concept Code C77595. SMILES: BRC1C(NC(=O)C(NC(=O)OCC2CCCCC2)CSSCC(NC(=O)OCC2CCCCC2)C(=O)NC2C(CN(C3CCCCC3)C)CC(BR)CC2BR)C(CN(C2CCCCC2)C)CC(BR)C1.

Same parent

Under 51162700 · 48

51162701 Acetylcysteine Commodity 51162702 Ambroxol Commodity 51162703 Amidephrine Commodity 51162704 Bromhexine Commodity 51162705 Brovanexine Commodity 51162706 Carbocisteine Commodity 51162707 Cartasteine Commodity 51162708 Domiodol Commodity 51162709 Cistinexine You are here 51162710 Eprazinone Commodity 51162711 Erdosteine Commodity 51162712 Fudosteine Commodity 51162713 Guaiacol Commodity 51162714 Guaiacol acetate Commodity 51162715 Guaiacol benzoate Commodity 51162716 Guaiacol butyrate Commodity 51162717 Guaiacol carbonate Commodity 51162718 Guaiacol nicotinate Commodity 51162719 Guaiacol phenylacetate Commodity 51162720 Letosteine Commodity 51162721 Mecysteine Commodity 51162722 Moguisteine Commodity 51162723 Guaiacol phosphate Commodity 51162724 Isalsteine Commodity 51162725 Guaiacol propionate Commodity 51162726 Guaietolin Commodity 51162727 Guaifenesin Commodity 51162728 Naphazoline Commodity 51162729 Neltenexine Commodity 51162730 Nesosteine Commodity 51162731 Oxedrine Commodity 51162732 Oxymetazoline Commodity 51162733 Prenisteine Commodity 51162734 Pseudoephedrine Commodity 51162735 Naphazoline nitrate Commodity 51162736 Pseudoephedrine sulfate Commodity 51162737 Pseudoephedrine tannate Commodity 51162738 Sobrerol Commodity 51162739 Stepronin Commodity 51162740 Tasuldine Commodity 51162741 Taurosteine Commodity 51162742 Telmesteine Commodity 51162743 Terpin hydrate Commodity 51162744 Tetrahydrozoline or tetryzoline Commodity 51162745 Tiopronin Commodity 51162746 Tyloxapol Commodity 51162747 Xylometazoline Commodity 51162748 Sterile water for inhalation Commodity

Activities that produce or sell this

KBLI · 9

Inherited from family 51160000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47111 Perdagangan Eceran Berbagai Macam Barang yang Utamanya Makanan, Minuman, atau Tembakau dengan Sistem Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class